browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
9762fa02-ba43-4be1-aef5-f223c4bc69f2
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 19:26:42
Income (reported)
—
Expenses (reported)
—
Filing document
Open on lda.senate.gov
Registrant (lobbying firm)

EMERGENT STRATEGIES

government affairs consulting firm

Contact
SCOTT ECKART
Phone
+1 202-907-5767
Address
zip:20002, city:WASHINGTON, state:DC, street:320 MASSACHUSETTS AVE NE
Client

GENBIOPRO, INC.

Generic Pharmaceutical Manufacturer

State
NV
Country
US
Effective date
2022-07-01
Issues lobbied + lobbyists (3)

PHA — Pharmacy

FDA Approval of generic mifepristone and relate Risk Evaluation Mitigation Strategies (REMS)

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

VET — Veterans

VA rule making on providing abortion services to veterans

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

HCR — Health Issues

Issues related to medication abortion; Issues related to abortion access

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.